UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial

The lancet oncology, 2018-12, Vol.19 (12), p.1602-1616

2018

Volltextzugriff (PDF)

Mutation of a putative MAP kinase consensus site regulates NCAM endocytosis and NCAM-dependent neurite outgrowth

Neuroscience research, 2017-07, Vol.120, p.28-35

2017

Volltextzugriff (PDF)

Medulloblastoma and Cowden syndrome: Further evidence of an association

Free Neuropathology, 2022, Vol.3

2022

Volltextzugriff (PDF)

MDB-25. LARGE CELL/ANAPLASTIC MEDULLOBLASTOMA REPRESENTS MORE THAN ONE DISEASE ENTITY

Neuro-oncology (Charlottesville, Va.), 2023-06, Vol.25 (Supplement_1), p.i67-i67

2023

Volltextzugriff (PDF)

FH -mutant glioma displaying the epigenetic signature of IDH -mutant astrocytomas

Journal of neuropathology and experimental neurology, 2024-06

2024

Volltextzugriff (PDF)

PTEN Mutations and Activation of the PI3K/Akt/mTOR Signaling Pathway in Papillary Tumors of the Pineal Region

Journal of neuropathology and experimental neurology, 2014-08, Vol.73 (8), p.747-751

2014

Volltextzugriff (PDF)

MEDB-61. Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i120-i120

2022

Volltextzugriff (PDF)

Medulloblastoma in Adults: Cytogenetic Phenotypes Identify Prognostic Subgroups

Journal of neuropathology and experimental neurology, 2021-05, Vol.80 (5), p.419-430

2021

Volltextzugriff (PDF)

FGFR1 Mutations in Rosette-Forming Glioneuronal Tumors of the Fourth Ventricle

Journal of neuropathology and experimental neurology, 2014-06, Vol.73 (6), p.580-584

2014

Volltextzugriff (PDF)

ETMR-11. RECURRENT GENETIC ALTERATIONS IN EPIGENETICALLY DEFINED PINEOBLASTOMA SUBTYPES

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

Supratentorial ependymomas of childhood carry C11orf95–RELA fusions leading to pathological activation of the NF-κB signaling pathway

Acta neuropathologica, 2014-04, Vol.127 (4), p.609-611

2014

Volltextzugriff (PDF)

Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas

Acta neuropathologica, 2022-12, Vol.144 (6), p.1143-1156

2022

Volltextzugriff (PDF)

Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters

Journal of clinical oncology, 2016-12, Vol.34 (34), p.4151-4160

2016

Volltextzugriff (PDF)

Genomic Alterations of Adamantinomatous and Papillary Craniopharyngioma

Journal of neuropathology and experimental neurology, 2017-02, Vol.76 (2), p.126-134

2017

Volltextzugriff (PDF)

Medulloblastoma in children with Fanconi anemia: Association with FA-D1/FA-N, SHH type and poor survival independent of treatment strategies

Neuro-oncology (Charlottesville, Va.), 2024-06

2024

Volltextzugriff (PDF)

MEDB-68. Analysis of telomeres length and Alternative Lengthening of Telomeres (ALT) in molecular subgroups of infant medulloblastoma

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i122-i122

2022

Volltextzugriff (PDF)

NFS-03. MEDULLOBLASTOMA IN CHILDREN WITH FANCONI ANEMIA: ASSOCIATION WITH FA-D1/FA-N, SHH TYPE AND POOR SURVIVAL INDEPENDENT OF TREATMENT STRATEGIES

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

MEDB-35. Relationship between genetic profile, histology, clinical features and long-term outcome in young children medulloblastoma (YCMB) treated with upfront high dose chemotherapy (HDCT) in Italy

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i112-i113

2022

Volltextzugriff (PDF)

PATH-32. GENOMIC LANDSCAPE AND BIOLOGY OF MEDULLOBLASTOMA IN ADULTS

Neuro-oncology (Charlottesville, Va.), 2019-11, Vol.21 (Supplement_6), p.vi150-vi150

2019

Volltextzugriff (PDF)

MPTH-52. GENOMIC LANDSCAPE OF ADULT MEDULLOBLASTOMAS CLASSIFIED ACCORDING TO WHO 2016 GUIDELINES

Neuro-oncology (Charlottesville, Va.), 2016-11, Vol.18 (suppl_6), p.vi117-vi117

2016

Volltextzugriff (PDF)

RARE-12. Pineoblastoma of children and young adults in a national population: An analysis of the HIT-MED study cohort

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i11-i12

2022

Volltextzugriff (PDF)

Dysembryoplastic Neuroepithelial Tumor of the Septum Pellucidum and the Supratentorial Midline: Histopathologic, Neuroradiologic, and Molecular Features of 7 Cases

The American journal of surgical pathology, 2016-06, Vol.40 (6), p.806-811

2016

Volltextzugriff (PDF)

Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts

Acta neuropathologica, 2023-01, Vol.145 (1), p.97-112

2023

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(43)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial

Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort

Mutation of a putative MAP kinase consensus site regulates NCAM endocytosis and NCAM-dependent neurite outgrowth

Medulloblastoma and Cowden syndrome: Further evidence of an association

MDB-25. LARGE CELL/ANAPLASTIC MEDULLOBLASTOMA REPRESENTS MORE THAN ONE DISEASE ENTITY

FH -mutant glioma displaying the epigenetic signature of IDH -mutant astrocytomas

PTEN Mutations and Activation of the PI3K/Akt/mTOR Signaling Pathway in Papillary Tumors of the Pineal Region

MEDB-61. Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas

Medulloblastoma in Adults: Cytogenetic Phenotypes Identify Prognostic Subgroups

FGFR1 Mutations in Rosette-Forming Glioneuronal Tumors of the Fourth Ventricle

ETMR-11. RECURRENT GENETIC ALTERATIONS IN EPIGENETICALLY DEFINED PINEOBLASTOMA SUBTYPES

Supratentorial ependymomas of childhood carry C11orf95–RELA fusions leading to pathological activation of the NF-κB signaling pathway

Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas

Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters

Genomic Alterations of Adamantinomatous and Papillary Craniopharyngioma

Medulloblastoma in children with Fanconi anemia: Association with FA-D1/FA-N, SHH type and poor survival independent of treatment strategies

MEDB-68. Analysis of telomeres length and Alternative Lengthening of Telomeres (ALT) in molecular subgroups of infant medulloblastoma

NFS-03. MEDULLOBLASTOMA IN CHILDREN WITH FANCONI ANEMIA: ASSOCIATION WITH FA-D1/FA-N, SHH TYPE AND POOR SURVIVAL INDEPENDENT OF TREATMENT STRATEGIES

MEDB-35. Relationship between genetic profile, histology, clinical features and long-term outcome in young children medulloblastoma (YCMB) treated with upfront high dose chemotherapy (HDCT) in Italy

PATH-32. GENOMIC LANDSCAPE AND BIOLOGY OF MEDULLOBLASTOMA IN ADULTS

MPTH-52. GENOMIC LANDSCAPE OF ADULT MEDULLOBLASTOMAS CLASSIFIED ACCORDING TO WHO 2016 GUIDELINES

RARE-12. Pineoblastoma of children and young adults in a national population: An analysis of the HIT-MED study cohort

Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification

Dysembryoplastic Neuroepithelial Tumor of the Septum Pellucidum and the Supratentorial Midline: Histopathologic, Neuroradiologic, and Molecular Features of 7 Cases

Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts

Suchergebnisse filtern